169 related articles for article (PubMed ID: 33843888)
1. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Davids MS
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
[No Abstract] [Full Text] [Related]
2. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):1-24. PubMed ID: 33843887
[No Abstract] [Full Text] [Related]
3. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
Awan FT
Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
[No Abstract] [Full Text] [Related]
4. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):1-20. PubMed ID: 33843855
[No Abstract] [Full Text] [Related]
5. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Barr PM
Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
[No Abstract] [Full Text] [Related]
6. Highlights in chronic graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
DiPersio JF
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):20-23. PubMed ID: 33843914
[No Abstract] [Full Text] [Related]
7. Highlights in chronic lymphocytic leukemia from the 2020 American Society of Clinical Oncology Annual Meeting: commentary.
O'Brien SM
Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 13(9):13-17. PubMed ID: 33843885
[No Abstract] [Full Text] [Related]
8. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):1-20. PubMed ID: 33843915
[No Abstract] [Full Text] [Related]
9. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Evens AM
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
[No Abstract] [Full Text] [Related]
10. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Garcia-Manero G
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
[No Abstract] [Full Text] [Related]
11. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Jacobson CA
Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):19-23. PubMed ID: 33843918
[No Abstract] [Full Text] [Related]
12. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Salles G
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858
[No Abstract] [Full Text] [Related]
13. Advances in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
Coombs CC
Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):15-19. PubMed ID: 35343945
[No Abstract] [Full Text] [Related]
14. Developments in the treatment of lymphoproliferative disorders: rising to the new challenges of CLL therapy. A report of a symposium presented during the 48th American Society of Hematology Annual Meeting and Exposition, December 8, 2006, Orlando, Florida.
Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 5):1-14; quiz 15-6. PubMed ID: 17519887
[No Abstract] [Full Text] [Related]
15. Highlights in chronic lymphocytic leukemia from the 2020 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 13(9):1-20. PubMed ID: 33843884
[No Abstract] [Full Text] [Related]
16. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
[No Abstract] [Full Text] [Related]
17. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):1-24. PubMed ID: 33843865
[No Abstract] [Full Text] [Related]
18. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):1-24. PubMed ID: 33843917
[No Abstract] [Full Text] [Related]
19. Highlights in graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):1-24. PubMed ID: 33843913
[No Abstract] [Full Text] [Related]
20. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):1-20. PubMed ID: 33843857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
